It was noted that interactions of miR-203 with ZEB1 and ZEB2 suppressed metastasis and EMT in multiple cancers and, in addition, antimetastatic miR-203, inhibiting ZEB2, reduced tumor stemness and chemotherapy resistance, for example, in nasopharyngeal carcinoma [31]. Here, ZEB2 is linked to nasopharyngeal carcinoma.